Prediction of Severity of Liver Disease Non Alcoholic Fatty Liver Disease in Patients With Suspected NAFLD by a 13C Octanoate Breath Test

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Exalenz Bioscience LTD.
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01281059
First received: January 10, 2011
Last updated: August 27, 2012
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given